Page last updated: 2024-08-16

ro 31-8220 and hymenialdisine

ro 31-8220 has been researched along with hymenialdisine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flajolet, M; Greengard, P; Meijer, L1
Jagarlapudi, SA; Sinha, BN; Tajne, S; Vadivelan, S1

Reviews

1 review(s) available for ro 31-8220 and hymenialdisine

ArticleYear
Pharmacological inhibitors of glycogen synthase kinase 3.
    Trends in pharmacological sciences, 2004, Volume: 25, Issue:9

    Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship

2004

Other Studies

1 other study(ies) available for ro 31-8220 and hymenialdisine

ArticleYear
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:6

    Topics: Algorithms; Computer Simulation; Databases, Factual; Drug Design; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Models, Chemical; Models, Molecular; Molecular Structure; Oxazines; Protein Kinase Inhibitors; Quinazolines; Reproducibility of Results; Stereoisomerism; Structure-Activity Relationship

2009